Press Room

Press Releases and Statements

Back

Print

PATH Develops Technology That Protects Hepatitis B Vaccine From Temperature Damage - Bill & Melinda Gates Foundation

Breakthrough formulation methods, recently published in <em>Human Vaccines and Vaccine</em>, help to stabilize hepatitis B vaccine when temperatures rise and fall

SEATTLE, WA -- PATH scientists and collaborators have developed formulation methods that protect hepatitis B vaccine from heat and freeze damage, helping to ensure the potency of hepatitis B vaccine in areas of the world where the cold chain is insufficient. For the full press release, visit the PATH web site.

Visit Our Blog

Connect